Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (7.407%)
Market Cap: £17.67m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Board changes

30 May 2024 07:00

RNS Number : 3612Q
Insig AI Plc
30 May 2024
 

30 May 2024

 

Insig AI

("Insig AI" or the "Company")

 

Board changes

 

Insig AI plc (AIM:INSG), the data science and machine learning solutions company announces the following changes to its board of directors (the "Board").

 

With immediate effect Colm McVeigh will be stepping down from the Board and his role as CEO to pursue other opportunities. Richard Bernstein has been appointed as Chief Executive Officer with immediate effect to devote more time to engaging with asset managers, prospective customers and commercialising Insig's product offering.

 

The Company also announces that Warren Pearson, Chief Technical Officer is stepping down from the Board, but staying within the business as a full-time employee. This change will allow Warren to focus time on product development and deployment of Insig's machine learning solutions.

 

Finally, Insig AI is pleased to announce the appointment of John Wilson as Independent Non-Executive Chairman with immediate effect.

 

John is a globally experienced Chairman and Chief Executive, with a strong background in the technology sector. He is currently the CEO of Bulgin Limited, a world leading manufacturer of sealed connectors and components and Independent Non-Executive Director of AIM quoted Volex plc. Previously, John previously held the roles of Senior Independent Director, Chair of the Audit Committee and Chair of the Remuneration Committee of Checkit plc (previously Elektron Technology plc), prior to which he was CEO of Elektron Technology Plc for almost a decade. John holds a degree in Engineering from the University of Durham.

 

Following the above changes the composition of the Board is as follows:

 

- Independent Non-Executive Chairman, John Wilson

- Independent Non-Executive Director, Richard Cooper

- Chief Executive Officer, Richard Bernstein

- Chief Product Officer, Steve Cracknell

 

Richard Bernstein, CEO commented: "I'm pleased to be appointed Chief Executive at a time when the priority for the business is to convert its strong machine learning repository and data science capabilities into client wins and revenues. Although sales cycles to large corporates for emerging technologies can take up to 18 months, with impending regulatory changes, our addressable market has enormous potential. Over time, my job will be to ensure that we fully capitalise on these substantial opportunities."

 

John Wilson commented: "I am delighted to be joining Insig AI at this exciting time. Having previously been involved in the business, as Strategic Adviser, I have had the opportunity to appreciate the significant potential for this business. I look forward to supporting Richard and the team in realising the true potential of Insig AI. "

 

The following additional information is provided in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

John Frederick Wilson (aged 48) holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

 

Previous Directorships or Partnerships

 

Volex Plc

Hartest Precision Instruments India Private Limited

JFW Agritech Ltd

Hartest Precision Instruments Limited

Regatta Midco Limited

Elektron Vision Inc.

Regatta Bidco Limied

Checkit UK Limited

Regatta Topco Limited

Elektron Eye Technology Limited

Regatta Holdco Limited

Elektron IP Limited

Bulgin Limited

Checkit Europe Limited

Bulgin Inc.

Elecktron Precision Instruments Limited

Munro Instruments Limited

Abbey Place (Fordham) Management Company Limited

Checkit Plc

Bulgin Connectors Limited

Elektron Enterprises 1 Limited

 

Mr Wilson and persons closely associated currently hold 800,000 ordinary shares in the Company.

 

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

 

 

For further information, please visit www.insg.ai or contact:

Insig AI plc

Richard Bernstein, CEO

 

richard.bernstein@insg.ai

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold

+44 (0) 203 829 5000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKLLLZELEBBQ
Date   Source Headline
1st Jun 20267:00 amRNSEquity subscription raising £0.2m and TVR
30th Apr 20267:00 amRNSNon-executive Directors’ Remuneration in Shares
22nd Apr 20267:00 amRNSEquity Subscription, TVR and PDMR Dealing
20th Apr 20267:00 amRNS-RCentral Bank MCP server in action
13th Apr 20267:00 amRNS-RLaunch of Central Bank Model Context Protocol
7th Apr 20267:01 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSPDMR Dealings
1st Apr 20267:00 amRNSTrading update and potential NASDAQ listing
3rd Mar 20267:00 amRNSInsig AI contract win and revenue share agreement
28th Jan 20267:00 amRNSGrant of Share Options
28th Jan 20267:00 amRNSPDMR Dealing
27th Jan 20267:00 amRNSPDMR Dealing
11th Dec 20257:00 amRNSDirector Dealings
9th Dec 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSNew contract with global advisory firm
29th Oct 20257:00 amRNS-RNew client win: new vertical market breakthrough
27th Oct 20257:00 amRNS-RMelloLondon Investor Event
16th Oct 20253:51 pmRNSResult of AGM
16th Oct 20257:00 amRNSTrading update & extended CLNs and warrant terms
8th Oct 202511:43 amRNSEquity fundraise
7th Oct 20257:00 amRNSEquity fundraise
1st Oct 20257:00 amRNSAppointment of Digital Asset Adviser
22nd Sep 20257:00 amRNSSubscription, Director Dealing & TVR
19th Sep 20257:00 amRNSFinal Results, Posting of AR&A and Notice of AGM
30th Jul 20257:00 amRNS-RLaunch of New Website and Corporate Brand Update
24th Jul 20257:00 amRNSDirector Dealing and Total Voting Rights
3rd Jul 20257:00 amRNSAppointment - Strategic & Asset Allocation Adviser
24th Jun 20257:05 amRNS-RAppointment of Business Development Director
24th Jun 20257:00 amRNSEquity Funding, Subscription, TVR & PDMR Dealing
6th Jun 20257:00 amRNSPDMR Dealings
20th May 20257:00 amRNS-RNew client win and additional sales prospects
12th May 20257:00 amRNS-RMello2025 Investor Event
8th May 20257:00 amRNS-RStrategic client win and new GIE product launch
6th May 20258:00 amRNS-RInsig AI & Falcon Windsor publish research re FTSE
29th Apr 20257:00 amRNSTrading Update and New Client Win
15th Apr 20257:00 amRNSPDMR Dealings
27th Mar 20257:00 amRNSPDMR Dealings
26th Mar 20257:00 amRNSPDMR Dealings
25th Mar 20257:00 amRNSPDMR Dealings
24th Mar 20257:03 amRNSTransfer of Share Options
24th Mar 20257:00 amRNSTrading Update, Equity Subscription, Funding & TVR
13th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20259:21 amRNSReplacement: Change of website address
3rd Mar 20257:00 amRNSChange of website address
17th Feb 20257:00 amRNSNew Client Win and Revenue Share Partnership
19th Dec 20247:00 amRNSInterim Results
22nd Nov 20247:00 amRNSNew business win
11th Oct 20247:00 amRNSDirector Dealing
2nd Oct 202411:14 amRNSPDMR Dealing
30th Sep 20242:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.